84 related articles for article (PubMed ID: 30615481)
21. WISP1/CCN4 inhibits adipocyte differentiation through repression of PPARγ activity.
Ferrand N; Béreziat V; Moldes M; Zaoui M; Larsen AK; Sabbah M
Sci Rep; 2017 May; 7(1):1749. PubMed ID: 28496206
[TBL] [Abstract][Full Text] [Related]
22. Regulation of PPARgamma activity during adipogenesis.
Farmer SR
Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S13-6. PubMed ID: 15711576
[TBL] [Abstract][Full Text] [Related]
23. Impact of metabolic regulators on the expression of the obesity associated genes FTO and NAMPT in human preadipocytes and adipocytes.
Friebe D; Löffler D; Schönberg M; Bernhard F; Büttner P; Landgraf K; Kiess W; Körner A
PLoS One; 2011; 6(6):e19526. PubMed ID: 21687707
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional activation of Cidec by PPARgamma2 in adipocyte.
Kim YJ; Cho SY; Yun CH; Moon YS; Lee TR; Kim SH
Biochem Biophys Res Commun; 2008 Dec; 377(1):297-302. PubMed ID: 18845124
[TBL] [Abstract][Full Text] [Related]
25. Activating transcription factor 4 regulates adipocyte differentiation via altering the coordinate expression of CCATT/enhancer binding protein β and peroxisome proliferator-activated receptor γ.
Yu K; Mo D; Wu M; Chen H; Chen L; Li M; Chen Y
FEBS J; 2014 May; 281(10):2399-409. PubMed ID: 24673832
[TBL] [Abstract][Full Text] [Related]
26. Nicotinamide phosphoribosyltransferase inhibits receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation in vitro.
Baek JM; Ahn SJ; Cheon YH; Lee MS; Oh J; Kim JY
Mol Med Rep; 2017 Feb; 15(2):784-792. PubMed ID: 28035412
[TBL] [Abstract][Full Text] [Related]
27. Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages.
Mayi TH; Duhem C; Copin C; Bouhlel MA; Rigamonti E; Pattou F; Staels B; Chinetti-Gbaguidi G
FEBS J; 2010 Aug; 277(16):3308-20. PubMed ID: 20608974
[TBL] [Abstract][Full Text] [Related]
28. The NAMPT promoter is regulated by mechanical stress, signal transducer and activator of transcription 5, and acute respiratory distress syndrome-associated genetic variants.
Sun X; Elangovan VR; Mapes B; Camp SM; Sammani S; Saadat L; Ceco E; Ma SF; Flores C; MacDougall MS; Quijada H; Liu B; Kempf CL; Wang T; Chiang ET; Garcia JG
Am J Respir Cell Mol Biol; 2014 Nov; 51(5):660-7. PubMed ID: 24821571
[TBL] [Abstract][Full Text] [Related]
29. HDAC inhibitor sodium butyrate augments the MEF2C enhancement of Nampt expression under hypoxia.
Yan SF; You HJ; Xing TY; Zhang CG; Ding W
Curr Pharm Des; 2014; 20(11):1604-13. PubMed ID: 23888946
[TBL] [Abstract][Full Text] [Related]
30. Histone H3K9 Demethylase JMJD2B Activates Adipogenesis by Regulating H3K9 Methylation on PPARγ and C/EBPα during Adipogenesis.
Jang MK; Kim JH; Jung MH
PLoS One; 2017; 12(1):e0168185. PubMed ID: 28060835
[TBL] [Abstract][Full Text] [Related]
31. Increased glycogen synthase kinase-3β and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity.
Yan C; Yang H; Wang Y; Dong Y; Yu F; Wu Y; Wang W; Adaku U; Lutfy K; Friedman TC; Tian S; Liu Y
Int J Obes (Lond); 2016 Aug; 40(8):1233-41. PubMed ID: 27102048
[TBL] [Abstract][Full Text] [Related]
32. ATF3 inhibits PPARγ-stimulated transactivation in adipocyte cells.
Jang MK; Jung MH
Biochem Biophys Res Commun; 2015 Jan; 456(1):80-5. PubMed ID: 25446101
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulation in adipogenesis through PPARγ-dependent and -independent mechanisms by prostaglandins.
Fujimori K; Urade Y
Methods Mol Biol; 2014; 1164():177-96. PubMed ID: 24927844
[TBL] [Abstract][Full Text] [Related]
34. Kirenol inhibits adipogenesis through activation of the Wnt/β-catenin signaling pathway in 3T3-L1 adipocytes.
Kim MB; Song Y; Kim C; Hwang JK
Biochem Biophys Res Commun; 2014 Mar; 445(2):433-8. PubMed ID: 24530909
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptor-gamma transcriptionally up-regulates hormone-sensitive lipase via the involvement of specificity protein-1.
Deng T; Shan S; Li PP; Shen ZF; Lu XP; Cheng J; Ning ZQ
Endocrinology; 2006 Feb; 147(2):875-84. PubMed ID: 16269451
[TBL] [Abstract][Full Text] [Related]
36. Low-level perfluorooctanoic acid enhances 3 T3-L1 preadipocyte differentiation via altering peroxisome proliferator activated receptor gamma expression and its promoter DNA methylation.
Ma Y; Yang J; Wan Y; Peng Y; Ding S; Li Y; Xu B; Chen X; Xia W; Ke Y; Xu S
J Appl Toxicol; 2018 Mar; 38(3):398-407. PubMed ID: 29094436
[TBL] [Abstract][Full Text] [Related]
37. Small heterodimer partner-interacting leucine zipper protein inhibits adipogenesis by regulating peroxisome proliferator-activated receptor γ activity.
Jang H; Kim HJ; Kim DH; Park JK; Sun WS; Hwang S; Oh KB; Jang WG; Lee JW
Life Sci; 2015 Jul; 132():49-54. PubMed ID: 25896661
[TBL] [Abstract][Full Text] [Related]
38. Very low density lipoprotein receptor promotes adipocyte differentiation and mediates the proadipogenic effect of peroxisome proliferator-activated receptor gamma agonists.
Tao H; Hajri T
Biochem Pharmacol; 2011 Dec; 82(12):1950-62. PubMed ID: 21924248
[TBL] [Abstract][Full Text] [Related]
39. Citrate carrier promoter is target of peroxisome proliferator-activated receptor alpha and gamma in hepatocytes and adipocytes.
Damiano F; Gnoni GV; Siculella L
Int J Biochem Cell Biol; 2012 Apr; 44(4):659-68. PubMed ID: 22249025
[TBL] [Abstract][Full Text] [Related]
40. O-GlcNAc modification of PPARγ reduces its transcriptional activity.
Ji S; Park SY; Roth J; Kim HS; Cho JW
Biochem Biophys Res Commun; 2012 Jan; 417(4):1158-63. PubMed ID: 22226965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
